title: [Venous thromboembolism in children].
abstract: Venous thromboembolism is a rare condition in children, but the incidence appears to be increasing. Newborns and teenagers are at the highest risk of thrombosis, which is often triggered by a combination of risk factors, in particular: infection, central venous line or chemotherapy. The impact of thrombophilia is uncertain. International guidelines recommend screening for thrombophilia as part of the diagnostic set-up in children with thrombosis. Treatment of paediatric thrombosis with low-molecular-weight heparin appears safe, but the effectiveness remains to be established.
authors.affiliation: Børneafdelingen, Aalborg Sygehus, DK-9000 Aalborg. rt@rn.dk
authors.forename: Ruta
authors.initials: R
authors.lastname: Tuckuviene
authors.forename: Søren Paaske
authors.initials: SP
authors.lastname: Johnsen
authors.forename: Jon
authors.initials: J
authors.lastname: Helgestad
authors.forename: Jørgen
authors.initials: J
authors.lastname: Ingerslev
authors.forename: Søren Risom
authors.initials: SR
authors.lastname: Kristensen
mesh_terms: D000293:Adolescent; D002648:Child; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use; D006801:Humans; D015994:Incidence; D007231:Infant, Newborn; D012307:Risk Factors; D012851:Sinus Thrombosis, Intracranial / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology; D013923:Thromboembolism / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology; D019851:Thrombophilia / Q000150:complications / Q000175:diagnosis; D020246:Venous Thrombosis / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology
chemical_list: D005343:Fibrinolytic Agents; D006495:Heparin, Low-Molecular-Weight